study possibility use subtotal irradiation sti equivalent chemotherapy treatment NUMBER hodgkins disease patients aged NUMBER NUMBER NUMBER treated yrs therapy NUMBER patients 1st stage antitumor therapy rokus apparatus linear accelerator NUMBER mev used irradiation single dose NUMBER gy total dose gy day interval sti efficacy assessed response peripheral intrathoracic lymph nodes tumor foci lungs decrease liver spleen sizes decrease body temperature end night sweating NUMBER patients positive effect achieved NUMBER NUMBER patients absent NUMBER patients disease progression observed marked positive effect noted NUMBER previously untreated patients especially respect elimination signs intoxication conclusion sti employed treatment hodgkins disease patients method general cytostatic action sti causes noticeable prolonged leukopenia cycle polychemotherapy 1st 19th NUMBER NUMBER NUMBER NUMBER